The release of both HMGB1 and ATP also triggers the optimal presentation of tumor antigens to T lymphocytes.[171] Nevertheless, PDT‐mediated antitumor immune responses are insufficient to elicit all immunological pathways needed for effective cancer therapy. This evidence concerns the gene HMGB1 and neoplasm.